India Immuno-Oncology Drugs Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Cancer and Government Initiatives
The India Immuno-Oncology Drugs Market is estimated to be valued at US$265 Mn in 2022 and is expected to exhibit a CAGR of 13.1% over the forecast period of 2021 to 2028, as highlighted in a new report published by Coherent Market Insights.Market Overview:The India Immuno-Oncology Drugs Market refers to the use of immunotherapy in the treatment of cancer. Immunotherapy is a revolutionary...
0 Comments 0 Shares 1720 Views 0 Reviews
Sponsored